Basically, the mechanism involved in PP2A‐mediated BMI1 ubiquitination and proteasomal degradation associated with colorectal cancer; hence, HTfNPs exerted notable therapeutic effects as an anticancer therapeutic to target colorectal cancer. This evidence concerns the gene PTPA and colorectal cancer.